Skip to main content
Figure 3 | Molecular Cancer

Figure 3

From: Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System

Figure 3

Decrease in liver weights following antiangiogenic transposon gene therapy. Animals were sacrificed 21 days post-tumor injection, livers were extracted and weighed, to gauge effect of treatment on tumor load (mean +/- SD). Transposon (pKT2/BidAEL), and transposase (pPGKSB11) plasmid DNA amounts infused into animals are summarized below the bar graph. A, 25 μg high dose transposon plasmid; B, 10 μg low dose transposon plasmid. *P < 0.05; **P < 0.005, ***P < 0.0005

Back to article page